Drug Profile
ABT 269
Latest Information Update: 23 Jan 2013
Price :
$50
*
At a glance
- Originator Abbott Laboratories
- Class Gastrokinetics
- Mechanism of Action Motilin stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Gastrointestinal disorders